Jeff Schaffnit: Sanofi Highlights Progress in Hemophilia and ITP at ISTH 2026
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
“Looking back on the last few days, it’s clear that this year’s ISTH 2026 marked not only an important moment to reflect on the progress being made across rare blood disorders but also a time to reinforce the collective commitment driving innovation forward for patients.
I’m proud of the momentum Sanofi continues to build across our Rare Blood Disorders portfolio, from advances in hemophilia to continued progress in Immune Thrombocytopenia (ITP), where ongoing research is reshaping how we think about disease control.
What stands out most to me is what these milestones represent: years of collaboration among researchers, clinicians, patient communities and teams across Sanofi, all working toward the same goal of improving the day-to-day lives of people living with rare blood disorders.
Thank you to everyone whose dedication to chasing the miracles of science continues to turn scientific progress into meaningful impact for patients and families.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke
-
Oct 18, 2026, 00:07Irem Karaman Sebin: The Evidence Favoring Warfarin in High-Risk Antiphospholipid Syndrome
-
Oct 18, 2026, 00:07Emma Stevens: Lighting Up Buildings in Red and Blue for World Thrombosis Day